Seema Jaitly defines what constitutes a medication error and explains the process for accurate recording and reporting so that risks can be assessed and reduced. Download the
16 Feb, 2016
The latest MHRA Symposium was held on 6th November 2015 in London. Find out about all the latest updates the MHRA had and an overview of some of the presentations. This
Working in pharmacovigilance, I understand the challenge of all the different reports you’re required to submit, from the DSUR, RMP and PBRER. They all have similar sections
12 Feb, 2015
Valproic acid (VPA), di-n-propylacetic acid, was first synthetized in 1882 by Burton and used as a solvent for pre-clinical testing of lipophilic drugs (1). Its
02 Feb, 2015
It doesn’t matter how big or small your pharmaceutical company is, everyone has to go through the inspection process. It’s never going to be a pleasant experience but
02 Feb, 2015
Risk minimisation has become a crucial part of pharmacovigilance activities. Manufacturers and regulatory agencies are required to constantly monitor risks and adverse effects
28 Jan, 2015
The objective of a drug treatment is to deliver specific benefits to the patient. However, no drug is devoid of risk. Effective risk management ensures that expected benefits
Recent Posts
- EU QPPV/UK QPPV and local requirements: is this now a global role?
- Essjay Newsletter – October 2019
- Are your UK PV operations Brexit ready?
- New Approvals and Launches June
- Submitting Risk Management Plans on the New EU template: 3 tips
- How to Manage Compliant Reference Safety Information (RSI) and maintain compliance